LOOMIS SAYLES & CO L P

Holdings History for BIOMARIN PHARMACEUTICAL INC - NOTE 0.599% 8/0

Investment type: Debt / NOTE 0.599% 8/0

Holdings date	Change	Value $	Principal	Price	All Holders
31 Mar 2024	0%	$40,943,000	468,775	8734.04% ^*	Q1 2024
31 Dec 2023	0%	$55,200,000	572,489	9642.11% ^*	Q4 2023
30 Sep 2023	0%	$51,172,000	578,344	8848.02% ^*	Q3 2023
30 Jun 2023	0%	$50,983,000	588,170	8668.07% ^*	Q2 2023
31 Mar 2023	0%	$59,485,000	611,736	9723.97% ^*	Q1 2023
31 Dec 2022	0%	$78,239,000	756,006	10348.99% ^*	Q4 2022
30 Sep 2022	0%	$68,748,000	810,991	8477.04% ^*	Q3 2022
30 Jun 2022	0%	$68,184,000	822,783	8287.0% ^*	Q2 2022
31 Mar 2022	0%	$69,512,000	901,591	7709.93% ^*	Q1 2022
31 Dec 2021	0%	$80,014,000	905,641	8835.07% ^*	Q4 2021
30 Sep 2021	0%	$61,450,000	795,069	7728.89% ^*	Q3 2021
30 Jun 2021	0%	$63,851,000	765,231	8344.02% ^*	Q2 2021
31 Mar 2021	0%	$51,201,000	678,080	7550.88% ^*	Q1 2021
31 Dec 2020	0%	$55,568,000	633,683	8769.05% ^*	Q4 2020
30 Sep 2020	0%	$47,060,000	618,555	7608.05% ^*	Q3 2020
30 Jun 2020	0%	$118,256,000	958,774	12334.08% ^*	Q2 2020
31 Mar 2020	0%	$122,036,000	1,444,217	8449.98% ^*	Q1 2020
31 Dec 2019	0%	$131,688,000	1,557,517	8455.0% ^*	Q4 2019
30 Sep 2019	0%	$64,887,000	962,720	6739.97% ^*	Q3 2019
30 Jun 2019	0%	$122,039,000	942,949	12942.27% ^*	Q2 2019
31 Mar 2019	0%	$116,669,000	914,673	12755.27% ^*	Q1 2019
31 Dec 2018	0%	$76,542,000	898,912	8514.96% ^*	Q4 2018
30 Sep 2018	0%	$120,544,000	907,254	13286.69% ^*	Q3 2018
30 Jun 2018	0%	$115,932,000	920,529	12594.06% ^*	Q2 2018
31 Mar 2018	0%	$89,661,000	766,113	11703.36% ^*	Q1 2018
31 Dec 2017	0%	$70,193,000	565,150	12420.24% ^*	Q4 2017
30 Sep 2017	0%	$44,554,000	352,748	12630.55% ^*	Q3 2017

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.